QUIPT HOME MEDICAL CORP (QIPT) Stock Fundamental Analysis
NASDAQ:QIPT - Nasdaq - CA74880P1045 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to QIPT. QIPT was compared to 103 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of QIPT have multiple concerns. QIPT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year QIPT has reported negative net income.
QIPT had a positive operating cash flow in the past year.
In the past 5 years QIPT reported 4 times negative net income.
QIPT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
QIPT has a Return On Assets (-2.99%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -6.83%, QIPT is in line with its industry, outperforming 43.69% of the companies in the same industry.
QIPT has a Return On Invested Capital (0.14%) which is comparable to the rest of the industry.
QIPT had an Average Return On Invested Capital over the past 3 years of 2.55%. This is significantly below the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.99% | ||
| ROE | -6.83% | ||
| ROIC | 0.14% |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)2.55%
ROIC(5y)N/A
1.3 Margins
QIPT's Operating Margin of 0.14% is in line compared to the rest of the industry. QIPT outperforms 40.78% of its industry peers.
QIPT has a better Gross Margin (71.56%) than 88.35% of its industry peers.
QIPT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.14% | ||
| PM (TTM) | N/A | ||
| GM | 71.56% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), QIPT is destroying value.
QIPT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for QIPT has been increased compared to 5 years ago.
The debt/assets ratio for QIPT is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.41, we must say that QIPT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of QIPT (0.41) is worse than 76.70% of its industry peers.
The Debt to FCF ratio of QIPT is 4.91, which is a neutral value as it means it would take QIPT, 4.91 years of fcf income to pay off all of its debts.
QIPT's Debt to FCF ratio of 4.91 is fine compared to the rest of the industry. QIPT outperforms 66.99% of its industry peers.
A Debt/Equity ratio of 0.74 indicates that QIPT is somewhat dependend on debt financing.
QIPT's Debt to Equity ratio of 0.74 is in line compared to the rest of the industry. QIPT outperforms 47.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 4.91 | ||
| Altman-Z | 0.41 |
ROIC/WACC0.02
WACC7.7%
2.3 Liquidity
QIPT has a Current Ratio of 1.22. This is a normal value and indicates that QIPT is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of QIPT (1.22) is worse than 62.14% of its industry peers.
A Quick Ratio of 0.87 indicates that QIPT may have some problems paying its short term obligations.
With a Quick ratio value of 0.87, QIPT is not doing good in the industry: 71.84% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
The earnings per share for QIPT have decreased strongly by -80.00% in the last year.
QIPT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.92%.
Measured over the past years, QIPT shows a very strong growth in Revenue. The Revenue has been growing by 32.16% on average per year.
EPS 1Y (TTM)-80%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)10.92%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-10.29%
3.2 Future
The Earnings Per Share is expected to grow by 97.77% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 21.85% on average over the next years. This is a very strong growth
EPS Next Y32%
EPS Next 2Y20.9%
EPS Next 3Y16.35%
EPS Next 5Y97.77%
Revenue Next Year-3.59%
Revenue Next 2Y0.8%
Revenue Next 3Y1.65%
Revenue Next 5Y21.85%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
QIPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year QIPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QIPT indicates a rather cheap valuation: QIPT is cheaper than 98.06% of the companies listed in the same industry.
QIPT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. QIPT is cheaper than 96.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.78 | ||
| EV/EBITDA | 3.74 |
4.3 Compensation for Growth
A more expensive valuation may be justified as QIPT's earnings are expected to grow with 16.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.9%
EPS Next 3Y16.35%
5. Dividend
5.1 Amount
QIPT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1.8
-0.1 (-5.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners45.65%
Inst Owner Change6.51%
Ins Owners15.15%
Ins Owner Change53.95%
Market Cap77.56M
Analysts82
Price Target5.27 (192.78%)
Short Float %7.44%
Short Ratio2.41
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-45.98%
Min EPS beat(2)-124.09%
Max EPS beat(2)32.12%
EPS beat(4)1
Avg EPS beat(4)-255.78%
Min EPS beat(4)-540.96%
Max EPS beat(4)32.12%
EPS beat(8)1
Avg EPS beat(8)-522.14%
EPS beat(12)3
Avg EPS beat(12)-242.54%
EPS beat(16)4
Avg EPS beat(16)-226.56%
Revenue beat(2)0
Avg Revenue beat(2)-11.63%
Min Revenue beat(2)-20.53%
Max Revenue beat(2)-2.74%
Revenue beat(4)0
Avg Revenue beat(4)-7.82%
Min Revenue beat(4)-20.53%
Max Revenue beat(4)-2.74%
Revenue beat(8)1
Avg Revenue beat(8)-4.62%
Revenue beat(12)1
Avg Revenue beat(12)-4.57%
Revenue beat(16)2
Avg Revenue beat(16)-4.02%
PT rev (1m)-18.1%
PT rev (3m)-15.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.32 | ||
| P/FCF | 3.78 | ||
| P/OCF | 2.35 | ||
| P/B | 0.73 | ||
| P/tB | N/A | ||
| EV/EBITDA | 3.74 |
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.48
FCFY26.46%
OCF(TTM)0.76
OCFY42.48%
SpS5.61
BVpS2.47
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.99% | ||
| ROE | -6.83% | ||
| ROCE | 0.18% | ||
| ROIC | 0.14% | ||
| ROICexc | 0.15% | ||
| ROICexgc | 0.5% | ||
| OM | 0.14% | ||
| PM (TTM) | N/A | ||
| GM | 71.56% | ||
| FCFM | 8.48% |
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)2.55%
ROIC(5y)N/A
ROICexc(3y)2.81%
ROICexc(5y)N/A
ROICexgc(3y)9.78%
ROICexgc(5y)N/A
ROCE(3y)3.22%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
F-Score3
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 4.91 | ||
| Debt/EBITDA | 1.82 | ||
| Cap/Depr | 28.74% | ||
| Cap/Sales | 5.13% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.63% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 0.41 |
F-Score3
WACC7.7%
ROIC/WACC0.02
Cap/Depr(3y)26.65%
Cap/Depr(5y)21.79%
Cap/Sales(3y)4.61%
Cap/Sales(5y)3.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-80%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y32%
EPS Next 2Y20.9%
EPS Next 3Y16.35%
EPS Next 5Y97.77%
Revenue 1Y (TTM)10.92%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-10.29%
Revenue Next Year-3.59%
Revenue Next 2Y0.8%
Revenue Next 3Y1.65%
Revenue Next 5Y21.85%
EBIT growth 1Y-93.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1615.9%
EBIT Next 3Y157.9%
EBIT Next 5Y154.85%
FCF growth 1Y23.94%
FCF growth 3Y22.49%
FCF growth 5Y24.98%
OCF growth 1Y26.48%
OCF growth 3Y23.7%
OCF growth 5Y33.42%